COMPARISON OF CLOFIBRATE AND ITS DERIVATIVE METHYL CLOFENAPATE

被引：9

作者：

CRAIG, GM

机构：

来源：

ATHEROSCLEROSIS | 1972年 / 15卷 / 02期

关键词：

D O I：

10.1016/0021-9150(72)90076-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：265 / +

页数：1

相关论文

共 7 条

[1] BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
[2] CLINICAL TRIAL OF METHYL CLOFENAPATE (A DERIVATIVE OF CLOFIBRATE) IN PATIENTS WITH ESSENTIAL HYPERLIPIDEMIAS - WITH SPECIAL REFERENCE TO TYPE II (PRIMARY) HYPERLIPIDEMIA
CRAIG, GM
WALTON, KW
[J]. ATHEROSCLEROSIS, 1972, 15 (02) : 189 - &
[3] FAT TRANSPORT IN LIPOPROTEINS - AN INTEGRATED APPROACH TO MECHANISMS AND DISORDERS (CONTINUED)
FREDRICK.DS
LEVY, RI
LEES, RS
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (03) : 148 - +
[4] FREDRICKSON DONALD S., 1967, N ENGL J MED, V276, P34, DOI 10.1056/NEJM196701052760107
[5] FAT TRANSPORT IN LIPOPROTEINS - AN INTEGRATED APPROACH TO MECHANISMS AND DISORDERS (CONTINUED)
FREDRICKSON, DS
LEVY, RI
LEES, RS
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (02) : 94 - +
[6] THORP JM, 1970, ATHEROSCLEROSIS, P541
[7] THE SIGNIFICANCE OF CHANGES IN SERUM TRANSAMINASE LEVELS - REMARKS
WROBLEWSKI, F
[J]. JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1963, 3 (5-6): : 740 - 741